Overview

A Pilot Study for PK/PD Parameter of Colchicine in Chronic Kidney Disease Patient.

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
A pilot study for PK/PD parameter of colchicine in Chronic kidney disease patient.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Colchicine
Criteria
Inclusion Criteria:

- from 18yrs to 80yrs , man and women

- the patient who are taking colchicine

- On screening, the patient shows that MDRD GFR >= 10 ml/min and <= 50 ml/min

- the patient sign on the concent form

Exclusion Criteria:

- the patient have experience to take medication that have an effect on renal function

- At least, the average level of two separate blood pressure ( 2min interval ) shows
that SBP <= 100 mmHg or >=160 mmHg and DBP <=60 mmHg >=100 mmHg, or Heart rate < 40
beats/min or > 90 beats/min

- pregnancy or anticipate pregnancy with 6 month

- hypersensitivity to colchicine

- acute hepatitis or the level of AST or ALT is over 2times of normal range or the level
of bilirubin is over 2.0 mg/dL

- serum albumin < 3.5 mg/dL or > 5mg/dL

- urinary retension, prostatic hyperplasia

- the patient show gout attack on taking colchicine

- the patient who have gastro-intestinal disease ( ex, crohn's disease, acute or chronic
pancreatitis, ulcer )or who have the surgical history of gastrointestine.

- the patient who should take Atazanavir, Amprenavir, Apreptant, clarithromycin,
indinavir, itraconazole, ketoconazole, nefazodone, nelfinavir, ritonavir, saquinavir,
telithromycin, diltiazem, erythromycin, fluconazole, fosamprenavir, grapefruit juice,
verapamil, cyclosporine, ranolazine

- the patient who had taken part in the other study within 3months

- the patient who had gotten blood transfusion

- pregnant, breast feeding